+91 780-304-0404

Brachytherapy Market

Global Brachytherapy Market Size, Share & Trends Analysis Report, by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), by Type (Low-Dose Rate and High-Dose Rate) and Forecast, 2019 – 2025

Published: Dec 2019 | Report Code: OMR2020013 | Category : Medical Devices | Delivery Format: /

The global brachytherapy market is estimated to grow at a CAGR of 3.5% during the forecast period. The major factors encouraging the growth of the market include the rising prevalence of cancer coupled with the increasing demand for internal radiation therapy. As per the World Health Organization (WHO), the global burden of cancer is estimated to have increased to 18.1 million new incidences and 9.6 million deaths in 2018. Globally, the total number of people who are alive within 5 years of a cancer diagnosis, known as 5-year prevalence, is estimated to be 43.8 million in 2018. Effective prevention efforts may result in a reported decline of incidence rates for some cancers, including lung cancer (such as in men in Northern Europe and North America) and cervical cancer (such as in most regions apart from Sub-Saharan Africa). The top three cancer types in terms of incidence include lung, female breast, and colorectum.

The most common form of cancer treatment is radiation therapy, which is used alone or along with surgery or chemotherapy. Brachytherapy is a kind of internal radiation therapy that involves placing capsules, seeds or ribbons in the body or near the tumor. It supports to treat only a particular part of the body. Brachytherapy is often used for the treatment of cancers, including breast, prostate, head and neck, cervix and lung. Most probably, the major benefit of brachytherapy is that doctors can utilize a higher total dose of radiation for the treatment of a smaller area in a shorter duration and reduces the damage to surrounding tissues.

Segmentation

The global brachytherapy market is segmented based on indication and type. Based on the indication, the market is classified into breast cancer, gynecological cancer, prostate cancer, skin cancer, brain cancer, and other cancer types. Brachytherapy is being significantly used for the treatment of prostate cancer. Brachytherapy is highly effective on moderately and small-sized prostate glands. Based on type, the market is classified into low-dose-rate (LDR) brachytherapy and HDR brachytherapy. High dose rate (HDR) brachytherapy is generally a treatment option for men with intermediate-risk or locally advanced prostate cancer. Some men are required to have hormone treatment earlier undergoing their HDR brachytherapy procedure.

The hormone therapy will shrink the prostate gland and this will make it easier for radiation therapy to destroy the cancer cells. In this case, hormone treatment will be prescribed for a fixed time only. As per WHO, prostate cancer is the third most commonly diagnosed cancer, accounted for 7.1%or 1.3 million cases in 2018. This, in turn, is contributing to the demand for internal radiation therapy for prostate cancer. 

HDR brachytherapy is estimated to witness considerable share in the market

The demand for HDR brachytherapy has increased significantly owing to its convenience and effectiveness. HDR brachytherapy was developed to overcome the potential disadvantages of LDR brachytherapy, which include prolonged treatment time, radiation exposure to medical staff, applicator movement and mandatory hospitalization. The overwhelming benefits of HDR include less risk of radiation exposure for medical personnel and computerized optimization of dosimetry. As a result, it results in fewer chances of organ motion at the time of radiation delivery. HDR brachytherapy is often used for the treatment of prostate, head and neck cancers and cervical, however, the HDR systems’ flexibility facilitates the use of this technology for a broad range of malignancies.

Global Brachytherapy Market Share by Type, 2018 (%)

Global Brachytherapy Market Share by Type

Regional Outlook

Geographically, the global brachytherapy market is segmented into North America, Europe, Asia-Pacific, and RoW. North America is anticipated to hold the major share in the market owing to the significant rise in the cancer incidences and the remarkable adoption of radiation therapy in the region. As per the NCI, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the US. Radiation therapy has a significant role in cancer management.  As per the American Association for Cancer Research (AACR), in 2016, there were an estimated 10.5 million 5-year cancer survivors, of which 3.05 million received radiation therapy in the US. In 2016, radiation-treated survivors constituted 29% of all cancer survivors in the US. This, in turn, is contributing to the adoption of internal radiation therapy such as brachytherapy in the region.

Global Brachytherapy Market Growth, by Region 2019-2025

Global Brachytherapy Market Growth, by Region

Market Players Outlook

The major players in the market include Elekta AB, Best Medical Instruments, Inc., Eckert & Ziegler BEBIG, Varian Medical Systems, Inc. and AngioDynamics, Inc. Mergers and acquisitions, product launches, partnerships, and collaborations are some crucial strategies adopted by the market players to expand market share and gain a competitive advantage over their competitors. For instance, in September 2019, C4 Imaging LLC introduced the first prostate cancer treatment with the use of Orion, a new medical device that is designed to simplify the MRI usage in encouraging the treatment accuracy.

The Orion HDR Marker creates a well-defined, positive MRI signal and facilitates greater anatomical imaging properties of MRI that can be potentially used while planning treatment. Additionally, it offers the potential for an effective treatment that reduces the chances of side effects. As the popularity of HDR has increased significantly owing to its convenience and effectiveness, the use of MRI can provide more anatomical detail as compared to computed tomography (CT). As a result, the use of Orion HDR Marker can support the effective treatment of prostate cancer patients.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global brachytherapy market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Elekta AB

3.3.1.1. Overview

3.3.1.2. SWOT Analysis

3.3.1.3. Recent Developments

3.3.2. Best Medical International, Inc.

3.3.2.1. Overview

3.3.2.2. SWOT Analysis

3.3.2.3. Recent Developments

3.3.3. Eckert & Ziegler BEBIG

3.3.3.1. Overview

3.3.3.2. SWOT Analysis

3.3.3.3. Recent Developments

3.3.5. Varian Medical Systems, Inc.

3.3.3.4. Overview

3.3.3.5. SWOT Recent Developments

3.3.3.6. Recent Developments

3.3.4. AngioDynamics, Inc. 

3.3.4.1. Overview

3.3.4.2. SWOT Analysis

3.3.4.3. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. Global Brachytherapy Market by Indication

5.1.1. Breast Cancer

5.1.2. Gynecological Cancer 

5.1.3. Prostate Cancer

5.1.4. Skin Cancer

5.1.5. Brain Cancer

5.1.6. Others 

5.2. Global Brachytherapy Market by Type

5.2.1. Low-Dose Rate (LDR) Brachytherapy

5.2.2. High-Dose Rate (HDR) Brachytherapy

5.2.3. Other (Permanent Brachytherapy)

6. Regional Analysis

6.1. North America

6.1.1. US

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe 

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific 

6.4. Rest of the World

7. Company Profiles

7.1. AngioDynamics, Inc. 

7.2. Best Medical International, Inc. 

7.3. Boston Scientific Corp. 

7.4. C. R. Bard, Inc. (Becton, Dickinson & Co.)

7.5. C4 Imaging, LLC

7.6. Carl Zeiss Meditec AG

7.7. CIVCO Medical Solutions 

7.8. Eckert & Ziegler BEBIG

7.9. Elekta AB

7.10. General Electric Co.

7.11. Hologic, Inc.

7.12. iCAD, Inc. 

7.13. IsoAid LLC

7.14. Isoray, Inc. 

7.15. Merit Medical Systems, Inc.

7.16. Sensus Healthcare, Inc.

7.17. Sun Nuclear Corp.

7.18. Theragenics Corp.

7.19. Varian Medical Systems, Inc.

1. GLOBAL BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2018-2025 ($ MILLION)

2. GLOBAL BRACHYTHERAPY FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL BRACHYTHERAPY FOR GYNECOLOGICAL CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL BRACHYTHERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL BRACHYTHERAPY FOR SKIN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL BRACHYTHERAPY FOR BRAIN CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL BRACHYTHERAPY FOR OTHER CANCER TYPES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

9. GLOBAL LOW-DOSE RATE BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL HIGH-DOSE RATE BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

11. GLOBAL OTHER BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

13. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

14. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

15. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

16. EUROPEAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

17. EUROPEAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

18. EUROPEAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

19. ASIA-PACIFIC BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

20. ASIA-PACIFIC BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

21. ASIA-PACIFIC BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

22. REST OF THE WORLD BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

23. REST OF THE WORLD BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

1. GLOBAL BRACHYTHERAPY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

2. GLOBAL BRACHYTHERAPY MARKET SHARE BY TYPE, 2018 VS 2025 (%)

3. GLOBAL BRACHYTHERAPY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

6. UK BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD BRACHYTHERAPY MARKET SIZE, 2018-2025 ($ MILLION)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports